| 1 |
35053615 | CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma. | 2022 Jan 17 |
2 |
| 2 |
34575782 | Proline-Specific Fungal Peptidases: Genomic Analysis and Identification of Secreted DPP4 in Alkaliphilic and Alkalitolerant Fungi. | 2021 Sep 10 |
1 |
| 3 |
34783283 | Recent advancement in functional properties and toxicity assessment of plant-derived bioactive peptides using bioinformatic approaches. | 2021 Nov 16 |
2 |
| 4 |
32315321 | Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2). | 2020 |
2 |
| 5 |
29806214 | Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection. | 2019 Jan |
2 |
| 6 |
30255759 | Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors. | 2019 |
2 |
| 7 |
31357088 | CD26 in autoimmune diseases: The other side of "moonlight protein". | 2019 Oct |
2 |
| 8 |
29426867 | Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues. | 2018 Feb 9 |
3 |
| 9 |
29963014 | In Silico Approaches Applied to the Study of Peptide Analogs of Ile-Pro-Ile in Relation to Their Dipeptidyl Peptidase IV Inhibitory Properties. | 2018 |
2 |
| 10 |
30007720 | Hydrolysis of food-derived opioids by dipeptidyl peptidase IV from Lactococcus lactis spp. lactis. | 2018 Sep |
1 |
| 11 |
26919392 | Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system. | 2016 Jul |
5 |
| 12 |
26988064 | Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation. | 2016 Jun |
3 |
| 13 |
27395781 | Dipeptidyl peptidase 4 - An important digestive peptidase in Tenebrio molitor larvae. | 2016 Sep |
1 |
| 14 |
27410463 | Dipeptidyl peptidase 9 substrates and their discovery: current progress and the application of mass spectrometry-based approaches. | 2016 Sep 1 |
2 |
| 15 |
27431629 | [Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule]. | 2016 Jul |
1 |
| 16 |
27484974 | Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors. | 2016 Nov |
2 |
| 17 |
25723507 | Mechanisms of neurodegeration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors. | 2015 |
2 |
| 18 |
24099035 | Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else? | 2014 Mar 27 |
3 |
| 19 |
24516103 | Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition. | 2014 May |
1 |
| 20 |
25140306 | The nonglycemic actions of dipeptidyl peptidase-4 inhibitors. | 2014 |
2 |
| 21 |
25216328 | Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. | 2014 Dec |
1 |
| 22 |
23519473 | Identifying natural substrates for dipeptidyl peptidases 8 and 9 using terminal amine isotopic labeling of substrates (TAILS) reveals in vivo roles in cellular homeostasis and energy metabolism. | 2013 May 17 |
1 |
| 23 |
23579020 | Interaction of dipeptydil peptidase IV with amyloid peptides. | 2013 Jun |
1 |
| 24 |
23637126 | Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types. | 2013 Jul 11 |
1 |
| 25 |
23677473 | Dipeptidyl peptidase IV is a human and murine neutrophil chemorepellent. | 2013 Jun 15 |
1 |
| 26 |
24038034 | Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9. | 2013 Dec |
2 |
| 27 |
22525314 | Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity. | 2012 May 15 |
1 |
| 28 |
22561447 | Dipeptidyl peptidase-4 expression is reduced in Crohn's disease. | 2012 Aug 20 |
2 |
| 29 |
22726613 | Discovering novel α-aminoacyl-containing proline derivatives with potent and selective inhibitory activity against dipeptidyl peptidase IV: design, synthesis, biological evaluation, and molecular modeling. | 2012 Dec |
1 |
| 30 |
21510839 | Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein. | 2011 |
2 |
| 31 |
21834515 | Proline in transmembrane domain of type II protein DPP-IV governs its translocation behavior through endoplasmic reticulum. | 2011 Sep 20 |
1 |
| 32 |
22001206 | Role of a propeller loop in the quaternary structure and enzymatic activity of prolyl dipeptidases DPP-IV and DPP9. | 2011 Nov 4 |
1 |
| 33 |
20406072 | B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications. | 2010 Apr |
1 |
| 34 |
20540760 | Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase. | 2010 Jun 11 |
1 |
| 35 |
20572019 | The dimeric transmembrane domain of prolyl dipeptidase DPP-IV contributes to its quaternary structure and enzymatic activities. | 2010 Sep |
1 |
| 36 |
23675206 | Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV). | 2010 Dec |
2 |
| 37 |
19217790 | Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes. | 2009 Mar 1 |
1 |
| 38 |
19545486 | Expression pattern of dipeptidyl peptidase IV activity and/or structure homologues in cancer. | 2009 |
2 |
| 39 |
23495778 | Dipeptidyl peptidase-IV and related molecules: markers of malignancy? | 2008 Jun |
2 |
| 40 |
17113301 | Lead optimization of [(S)-gamma-(arylamino)prolyl]thiazolidine focused on gamma-substituent: Indoline compounds as potent DPP-IV inhibitors. | 2007 Jan 15 |
2 |
| 41 |
17300591 | Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug. | 2007 Mar |
1 |
| 42 |
17317162 | [(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors. | 2007 May 1 |
2 |
| 43 |
17352682 | Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery. | 2007 |
1 |
| 44 |
17676345 | 3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment. | 2007 Oct |
2 |
| 45 |
16321524 | In silico fragment-based discovery of DPP-IV S1 pocket binders. | 2006 Mar 1 |
1 |
| 46 |
16376544 | The reversed binding of beta-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitors. | 2006 Mar 15 |
1 |
| 47 |
16388667 | Proline-catalyzed, asymmetric mannich reactions in the synthesis of a DPP-IV inhibitor. | 2006 Jan 6 |
1 |
| 48 |
16687037 | Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions. | 2006 May |
2 |
| 49 |
16756746 | Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery. | 2006 Jun |
2 |
| 50 |
16769036 | Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha). | 2006 Jul 28 |
2 |